Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,399,969 | $1,053,034 | $1,233,148 | $1,266,157 |
| % Growth | 32.9% | -14.6% | -2.6% | – |
| Cost of Goods Sold | $646,614 | $501,723 | $462,393 | $459,873 |
| Gross Profit | $753,355 | $551,311 | $770,755 | $806,284 |
| % Margin | 53.8% | 52.4% | 62.5% | 63.7% |
| R&D Expenses | $83,829 | $96,804 | $168,885 | $243,835 |
| G&A Expenses | $195,298 | $188,612 | $198,413 | $297,265 |
| SG&A Expenses | $582,590 | $492,908 | $544,880 | $663,704 |
| Sales & Mktg Exp. | $387,292 | $304,296 | $346,467 | $366,439 |
| Other Operating Expenses | -$26,206 | -$81,954 | -$19,276 | -$18,156 |
| Operating Expenses | $640,213 | $507,758 | $694,489 | $889,383 |
| Operating Income | $113,142 | $43,553 | $123,019 | -$694 |
| % Margin | 8.1% | 4.1% | 10% | -0.1% |
| Other Income/Exp. Net | -$15,029 | -$12,768 | -$8,699 | -$9,217 |
| Pre-Tax Income | $98,113 | $30,785 | $67,861 | $1,969,366 |
| Tax Expense | $29,501 | $10,836 | $22,026 | $9,482 |
| Net Income | $93,099 | $16,698 | $51,284 | $1,987,176 |
| % Margin | 6.7% | 1.6% | 4.2% | 156.9% |
| EPS | 0.16 | 0.028 | 0.087 | 3.38 |
| % Growth | 463.4% | -67.4% | -97.4% | – |
| EPS Diluted | 0.16 | 0.028 | 0.087 | 3.37 |
| Weighted Avg Shares Out | 588,835 | 588,835 | 588,835 | 588,649 |
| Weighted Avg Shares Out Dil | 588,836 | 588,836 | 588,835 | 589,047 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,133 | $1,534 | $2,393 | $5,912 |
| Interest Expense | $13,823 | $11,898 | $6,619 | $4,404 |
| Depreciation & Amortization | $147,731 | $149,501 | $152,499 | $146,867 |
| EBITDA | $259,667 | $191,563 | $229,059 | $2,125,450 |
| % Margin | 18.5% | 18.2% | 18.6% | 167.9% |